Project Grant R21AI196576
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $417,845 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Nebraska Medical Center for a two-year project period extending from August 1, 2025 through July 31, 2027. The project involves developing an innovative in vitro organotypic human skin model adapted to support tick feeding and enable the study of Borrelia burgdorferi transmission and...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $518,099 to the University of Maryland, College Park on July 17, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct biomedical research investigating cross-species signaling mechanisms in tick immunity and pathogen response. The research examines how the tick species Ixodes scapularis senses and responds to mammalian-derived factors, particularly...
- Federal Grant Award Summary Tufts Medical Center received a $506,415 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 9, 2026, through January 31, 2028. The award supports research investigating the use of tafenoquine, an antimalarial drug approved for malaria pre-exposure prophylaxis, as both pre- and post-exposure prophylaxis against tick-transmitted babesiosis...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a $165,000 project grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 1, 2025, with a completion date of June 30, 2027. This award funds the development of an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi, the causative agent of Lyme disease. The primary deliverables...
- Federal Grant Award Summary The University of Connecticut Health Center received a $640,129 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025, through August 31, 2030. This award supports fundamental biomedical research focused on deciphering the regulatory networks of Borrelia burgdorferi (BB), the causative agent of Lyme disease, as it adapts between its tick...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Stony Brook University a $3.13 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 23, 2025, with completion targeted for June 30, 2029. The grant funds research to develop new therapeutic strategies targeting STS-1 and STS-2 phosphatases as a means to enhance antimicrobial immune responses. The project deliverables include the identification...
- Federal Grant Award Summary Yale University received a $461,375 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025 through June 30, 2027. The grant supports systematic identification of molecular interactions between Lyme disease bacteria (Borrelia burgdorferi) and its tick vector (Ixodes scapularis). The primary deliverable involves screening the ISCREAM (I....
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Connecticut Health Center a Project Grant totaling $457,875 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period February 10, 2026 through January 31, 2028. This award supports biomedical research investigating independent gene regulation by the Borrelia burgdorferi Fur ortholog (BosR), the causative agent of Lyme disease. The research...
- Federal Grant Award Summary Texas A&M Agrilife Research received a $423,106 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2027. The award supports research to characterize the role of tick metalloprotease inhibitors in the transmission of Borrelia burgdorferi, the causative agent of Lyme disease, by blacklegged nymphal ticks. The research...
- Federal Project Grant Award Summary Tufts University School of Medicine received a Project Grant award of $859,278 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 19, 2026, with completion targeted for January 31, 2031. The grant supports research focused on accelerating the discovery of narrow-spectrum antibiotics targeting Borrelia burgdorferi, the causative agent of Lyme...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Stony Brook University $436,605 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 4, 2026, with a completion date of January 31, 2028. This R21 Project Grant supports research investigating the capacity of the Haemaphysalis longicornis (longhorned tick) to acquire and transmit Babesia microti, an emerging vector-borne pathogen causing babesiosis in humans. The research addresses a critical public health gap by determining whether this invasive tick species serves as a competent vector for Babesia microti transmission, given its rapid spread in endemic regions such as Long Island, New York, and its potential to co-feed with the known primary vector, Ixodes scapularis. The research deliverables include experimental studies employing a customized artificial membrane feeding system to evaluate Haemaphysalis longicornis acquisition and transmission of Babesia microti, with measurements of transstadial and transovarial transmission efficiencies, parasitic burdens in organ tissues, and transmission capacity to sterile blood reservoirs. The study will include parallel investigations using laboratory-reared Ixodes scapularis ticks as control specimens to establish comparative vectorial competence data. These research products will provide essential scientific evidence regarding emerging tick-borne pathogen transmission dynamics and support informed public health interventions for managing babesiosis risk in the United States.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $436.6k | 2/4/26 |